integrated within the bioMérieux Sepsis Solution enables same-day Antimicrobial Susceptibility Testing (AST) results to help you manage bloodstream infections.
▶️ Check out this video to discover the new instrument
Benefits - Specific Reveal
- Delivers phenotypic AST results in an average of 5.5 hours*
- Direct from positive blood culture
*Clinical evaluation of the SPECIFIC REVEAL™ with Gram-negative bacteremia samples in 6 hospitals in France and England - 2021
- Wide antimicrobial coverage for Gram negative bloodstream infections
- Allows faster antimicrobial therapy de-escalation to support antimicrobial stewardship
- Real-time monitoring of Minimum Inhibitory Concentration (MIC) results
- Fully integrated within the bioMérieux Sepsis Solution
- Access to bioMérieux’s services from consultancy to installation
- Bi-directional connectivity with MYLA® or LIS
How it works
The bioMérieux Sepsis Solution
The bioMérieux Sepsis Solution, with the addition of SPECIFIC REVEAL™ helps manage patient therapy all along the pathway, bringing you rapid and reliable results to support clinical decisions for better patient care.